Trial · NCT04924036
Qbrexza Cloths for Hyperhidrosis of Amputation Sites
NCT04924036, Phase 2, Completed, University of Utah; results first posted 2026-01-22
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Qbrexza Cloths for Hyperhidrosis of Amputation Sites. Trials, record NCT04924036. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04924036
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Qbrexza Cloths for Hyperhidrosis of Amputation Sites
- NCT number
- NCT04924036
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 13 participants, actual
- Lead sponsor
- University of Utah
- Conditions
- Amputation, Hyperhidrosis
- Interventions
- glycopyrronium cloths, Placebo
- First posted
- 2021-06-11
- Last updated
- 2026-01-22
- Results first posted
- 2026-01-22
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | ASDD-m Sweat Severity Score | 4 weeks | ASDD-m is a questionnaire for axillary hyperhidrosis measuring for presence, severity, impact and bothersomeness of the patient's sweating. Question #1 is "Rate the Sweating at its worst" that a patient rates from 0-10 (0 meaning no sweating at all, and 10 meaning worst possible sweating). This single score was used from the number of responses listed below while patient was on active drug, and while they were on placebo. Patients completed this questionnaire daily throughout the study (4 weeks of glycopyrronium cloths, 1 week of washout, and 4 weeks of placebo). Therefore, each patient could have up to 28 entries, however, some patients ended the study early, and some missed a few surveys. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | ASDD-m Sweat Severity Score | 4 weeks | Patients completed this questionnaire daily throughout the study (4 weeks of active drug, 1 week washout, 4 weeks of placebo). | score on a scale of 0-10 | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| ASDD-m Sweat Severity Score | Glycopyrronium Cloths | 1.2 | Standard Deviation 2.0 | score on a scale of 0-10 | |
| ASDD-m Sweat Severity Score | Placebo | 3.6 | Standard Deviation 2.9 | score on a scale of 0-10 |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Glycopyrronium Cloths, Then Placebo | 7 | |
| Overall Study | STARTED | Placebo, Then Glycopyrronium Cloths | 6 | |
| Overall Study | COMPLETED | Glycopyrronium Cloths, Then Placebo | 3 | |
| Overall Study | COMPLETED | Placebo, Then Glycopyrronium Cloths | 4 | |
| Overall Study | NOT COMPLETED | Glycopyrronium Cloths, Then Placebo | 4 | |
| Overall Study | NOT COMPLETED | Placebo, Then Glycopyrronium Cloths | 2 |
Source ClinicalTrials.gov
Adverse events20
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dry Mouth | General disorders | Glycopyrronium Cloths | 2 | 13 | 2 |
| other | Dry Mouth | General disorders | Placebo | 0 | 13 | 0 |
| other | Folliculitis | Skin and subcutaneous tissue disorders | Glycopyrronium Cloths | 2 | 13 | 2 |
| other | Folliculitis | Skin and subcutaneous tissue disorders | Placebo | 2 | 13 | 2 |
| other | Anhidrosis | Skin and subcutaneous tissue disorders | Glycopyrronium Cloths | 1 | 13 | 1 |
| other | Anhidrosis | Skin and subcutaneous tissue disorders | Placebo | 0 | 13 | 0 |
| other | Exacerbated asthma | Respiratory, thoracic and mediastinal disorders | Glycopyrronium Cloths | 1 | 13 | 1 |
| other | Exacerbated asthma | Respiratory, thoracic and mediastinal disorders | Placebo | 0 | 13 | 0 |
| other | Irritant contact dermatitis | Skin and subcutaneous tissue disorders | Glycopyrronium Cloths | 1 | 13 | 1 |
| other | Irritant contact dermatitis | Skin and subcutaneous tissue disorders | Placebo | 1 | 13 | 1 |
1 to 10 of 20Source ClinicalTrials.gov
See all 20 adverse eventsAdverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Glycopyrronium Cloths | 0 | 13 |
| Total, all-cause mortality | Placebo | 0 | 13 |
| Total, other adverse events | Glycopyrronium Cloths | 5 | 13 |
| Total, other adverse events | Placebo | 3 | 13 |
| Total, serious adverse events | Glycopyrronium Cloths | 1 | 13 |
| Total, serious adverse events | Placebo | 0 | 13 |
Source ClinicalTrials.gov
Papers8
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Glycopyrronium Cloths vs Placebo: deaths from any cause | Trial comparisons |
| Glycopyrronium Cloths vs Placebo: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04924036
GET https://conductscience.org/api/trials/v1/NCT04924036/registered